Abstract
Morphine has been demonstrated to modulate immune function. We studied whether morphine modulates apoptosis of splenocytes. Splenocytes were isolated from control and morphine treated rats. Splenocytes isolated from morphine treated rats showed increased percentage (P < 0.001) of apoptosis when compared to splenocytes isolated from untreated rats (control, 4.7 ± 1.0% apoptotic splenocytes/field vs. morphine, 47.8 ± 3.4% apoptotic splenocytes/field). These results were further confirmed by gel electrophoresis as well as by end-labeling DNA of splenocytes isolated from control and morphine treated rats. Splenocytes from morphine treated rats showed a classical ladder pattern with integer multiples of 180 base pairs. Splenocytes from morphine treated rats also showed increased mRNA expression of cathepsin-B, a gene associated with active cell death. These results suggest that morphine may also be modulating immune function by enhancing apoptosis of splenocytes.
Similar content being viewed by others
REFERENCES
LOURIA, D. B., T. HENSLE, and J. ROSE. 1957. The major medical complications of heroin addiction. Ann. Intern. Med. 67:1–22.
BRIGGS, J. H., C. G. MCKERRON, R. I. SOUHAMI, D. J. E. TAYLOR, and H. ANDREWS. 1967. Severe systemic infections complicating mainline heroin addiction. Lancet 2:1227–1231.
CHERUBIN, C. E. 1971. The medical sequelae of heroin addiction. Arch. Intern. Med. 128:309–313.
TUBARO, E., G. BORELLI, C. CROSE, G. CAVALLO, and C. SANTIANGELI. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. 148:655–666.
MC DONAUGH, R. J., J. J. MADDEN, A. FALEK, D. A. SHAFER, M. PLINE, D. GORDON, P. BOKOS, J. C. KUEHNLE, and J. MENDELSON. 1980. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts. J. Immunol. 125:2539–2543.
BROWN, S. W., B. STIMMEL, R. N. TAUB, S. KOCHWA, and R. E. ROSENFIELD. 1974. Immunologic dysfunction in opiate addicts. Arch. Intern. Med. 134:1001.
WYBRAN, J., T. APPELBOOM, J. P. FAMAEY, and A. GOVAERTS. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1068–1070.
ARORA, P. K., E. FRIDE, J. PETTITO, K. WAGGIE, and P. SKOLNICK. 1990. Morphine-induced immune alterations in vivo. Cell Immunol. 126:343–353.
BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1987. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1731–1738.
SEI, Y., K. YOSHIMOTO, T. MCINTYRE, P. SKOLNICK, and P. K. ARORA. 1991, Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146:194–196.
FUCHS, B. A., and S. B. PRUETT. 1993. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 266:417–423.
THOMPSON, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462.
WYLLIE, A. H., J. F. R. KERR, and A. R. CURRIE. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:251–305.
SAVILL, J., V. FADOK, P. HENSON, and C. HASLETT. 1993. Phagocytic recognition of cells undergoing apoptosis. Immunol. Today 14:131–136.
OBERHAMMER, F., P. R. WILSON, and M. SIKORSKA. 1993. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:3679–3684.
FLIPSKI, J., J. LEBLANC, T. YOUDALE, M. SIKORSKA, and P. R. WALKER. 1990. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 9:1319–1327.
BROWN, D. G., X. M. SUN, and G. M. COHEN. 1993. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268:3037–3039.
WYLLIE, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555–556.
MARTIN, S. J., and D. R. GREEN. 1995. Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349–352.
NICHOLSON, D. W., A. ALI, N. A. THORNBERRY, J. P. VALLIANCOURT, C. K. DING, M. GALLANT, Y. GAREAU, P. R. GRIFFIN, M. LABELLE, Y. A. LAZEBNIK, N. A. MUNDAY, S. M. RAJU, S. E. SMULSON, T. T. YAMIN, V. L. YU, and D. K. MILLER. 1995. Identification and inhibition of the ICE/ced-3 protease necessary for mammalian apoptosis. Nature 376:37–43.
MICHEL, D., J. G. CHABOT, E. MOYSE, E. MOYSE, M. DANIK, and R. QUIRION. 1992. Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2), Synapse 11:105–111.
GUENETTE, R. S., M. MOOIBROEK, K. WONG, P. WONG, and M. TENNISWOOD. 1994. Cathepsin-B. A cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem. 226:311–321.
LIEBERTHAL, W., V. TRIACA, and J. LEVINE. 1996. Mechanism of death induced by cysplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am. J. Physiol. 270:F700–F708.
CHOMCZYNSKI, P., and N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidine thiocynate phenol-chloroform extraction. Anal. Biochem. 162:156–159.
SHAVIT, Y., A. DEPAULIS, F. C. MARTIN, G. W. TERMAN, R. P. GALE, and J. C. LIEBESKIND. 1986. Involvement of brain opiate receptors in the immune suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83:7114–7117.
WEBER, R. J., and A. PERT. 1989. The periaqueductal gray matter mediates opiate-induced immune suppression. Science 245:188–190.
HO, W. K. K., and A. LEUNG. 1979. The effect of morphine addiction on concanavalin A-mediated blastogenesis. Pharmacol. Res. Commun. 11:413–419.
BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1987. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1731–1738.
BRYANT, H. U., E. W. BERNTON, and J. W. HOLADAY. 1988. Morphine pellet-induced immunomodulation in mice: Temporal relationship. J. Pharmacol. Exp. Ther. 245:913–920.
BRYANT, H. U., E. W. BERNTON, J. R. KENNER, and J. W. HOLADAY. 1991. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128:3253–3258.
BRYANT, H. U., and R. E. ROUDEBUSH. 1990. Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255:410–415.
WEBER, R. J., B. IKEJIRI, K. C. RICE, A. PERT, and A. A. HAGAN. 1987. Opiate receptor-mediated regulation of the immune response in vivo. NIDA Res. Monogr. 76:341–348.
BAYER, B. M., M. R. GASTONGUAY, and M. C. HERNANDES. 1992. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonistic sensitivity and naltrexone reversibility. Immunopharmacology 23:117–124.
SEI, Y., T. MC INTYRE, E. FRIDE, K. YOSKIMOTO, P. SKOLNICK, and P. K. ARORA. 1991. Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression. FASEB J. 5:2194–2199.
LOPHER, A., L. G. ABOOD, W. HOSS, and F. J. LIONETTI. 1980. Steroselective muscarinic acetylcholine and opiate receptors in human phagocytic leucocytes. Biochem. Pharmacol. 29:1361–1365.
MEHRISHI, J. N., and I. H. MILLS. 1983. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27:240–249.
MADDEN, J. J., R. M. DONAHOE, J. ZWEMER-COLLINS, D. A. SHAFER, and A. FALEK. 1987. Binding of naloxone to human T lymphocytes. Biochem. Pharmacol. 36:4103–4109.
OVAIDA, H., P. NITSAN, and O. ABRAMSKY. 1989. Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 21:93–102.
OVAIDA, H., and O. ABRAMSKY. 1991. Opiate binding sites on rat lymphocytes. Prog. Neuroenodocrin. Immunol. 4:121–125.
RADULESCU, R. T., B. R. DE COSTA, A. E. JACOBSON, K. C. RICE, J. E. BLALOCK, and D. J. J. CARR. 1991. Biochemical and funtional characterization of a μ-opioid receptor binding site on cells of the immune system. Prog. Neuroendocrin. Immunol. 4:166–179.
TAUB, D. D., T. K. EISENSTEIN, E. B. GELLER, M. W. ADLER, and T. J. ROGERS. 1991. Immunomodulatory activity of kappa-, mu, and delta-selective opioid agonists. Proc. Natl. Acad. Sci. U.S.A. 88:360–364.
ROGERS, T. J., D. D. TAUB, T. K. EISENSTEIN, E. B. GELLER, and M. W. ADLER. 1991. Immunomodulatory activity of kappa-, mu-, and delta-selective opioid compounds. NIDA Res. Monogr. 105:82–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singhal, P.C., Reddy, K., Franki, N. et al. Morphine Induces Splenocyte Apoptosis and Enhanced mRNA Expression of Cathepsin-B. Inflammation 21, 609–617 (1997). https://doi.org/10.1023/A:1027334122387
Issue Date:
DOI: https://doi.org/10.1023/A:1027334122387